Skip to Main Content
Advertisement
Close
AACR Journals
Blood Cancer Discovery
Cancer Discovery
Cancer Epidemiology, Biomarkers & Prevention
Cancer Immunology Research
Cancer Prevention Research
Cancer Research
Cancer Research Communications
Clinical Cancer Research
Molecular Cancer Research
Molecular Cancer Therapeutics
For Authors
Information for Authors
Author Services
Journal Awards
Best of: Author Profiles
About Us
AACR Journals
Advertising
Permissions & Reprints
Subscriptions
Submit
Article Collections
Journal Collections
Hot Topics
'Best Of' Collection
Editors' Picks
COVID-19
Webinars
Search Dropdown Menu
header search
search input
Search input auto suggest
Search
Advanced Search
User Tools Dropdown
Register
Sign In
Toggle Menu
Menu
About
The Journal
AACR Journals
Subscriptions
Permissions and Reprints
Articles
Online First
Issues
Meeting Abstracts
Cancer Research Landmarks
Collection: Targeting the Tumor Microenvironment
Collection: Tumor-Host Interactions
Collection: Focus on Computer Resources
Collection: Editors' Picks
Collection: 'Best 'Of' Collection
For Authors
Information for Authors
Author Services
Best of: Author Profiles
Early Career Award
Submit
Alerts
News
COVID-19
Webinars
Skip Nav Destination
Issues
Select Decade
2020
2010
2000
1990
1980
1970
1960
1950
1940
Select Year
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Issue
1 January - Volume 76, Issue 1, Pages 1 - 182
15 January - Volume 76, Issue 2, Pages 183 - 505
15 January - Volume 76, Issue 2_Supplement
1 February - Volume 76, Issue 3, Pages 507 - 762
1 February - Volume 76, Issue 3_Supplement
15 February - Volume 76, Issue 4, Pages 763 - 985
15 February - Volume 76, Issue 4_Supplement
1 March - Volume 76, Issue 5, Pages 987 - 1297
1 March - Volume 76, Issue 5_Supplement
15 March - Volume 76, Issue 6, Pages 1299 - 1669
15 March - Volume 76, Issue 6_Supplement
1 April - Volume 76, Issue 7, Pages 1671 - 2053
1 April - Volume 76, Issue 7_Supplement
15 April - Volume 76, Issue 8, Pages 2055 - 2492
1 May - Volume 76, Issue 9, Pages 2493 - 2847
15 May - Volume 76, Issue 10, Pages 2849 - 3111
1 June - Volume 76, Issue 11, Pages 3113 - 3437
15 June - Volume 76, Issue 12, Pages 3439 - 3655
1 July - Volume 76, Issue 13, Pages 3657 - 4022
15 July - Volume 76, Issue 14, Pages 4023 - 4304
15 July - Volume 76, Issue 14_Supplement, Pages 2 - 5293
1 August - Volume 76, Issue 15, Pages 4305 - 4592
1 August - Volume 76, Issue 15_Supplement
15 August - Volume 76, Issue 16, Pages 4593 - 4910
1 September - Volume 76, Issue 17, Pages 4911 - 5186
15 September - Volume 76, Issue 18, Pages 5187 - 5584
1 October - Volume 76, Issue 19, Pages 5585 - 5908
15 October - Volume 76, Issue 20, Pages 5909 - 6133
1 November - Volume 76, Issue 21, Pages 6135 - 6436
15 November - Volume 76, Issue 22, Pages 6437 - 6759
1 December - Volume 76, Issue 23, Pages 6761 - 7072
15 December - Volume 76, Issue 24, Pages 7073 - 7303
15 December - Volume 76, Issue 24_Supplement
Volume 76, Issue 24_Supplement
15 December 2016
ISSN 0008-5472
EISSN 1538-7445
Close mobile search navigation
In this Issue
Clinical Investigation
Early Detection
Epidemiology and Risk Factors
Heterogeneity of Pancreatic Cancer
Immune Drug Development
Innovations and New Directions in Pancreatic Cancer Therapy
Molecular Drivers of Pancreatic Cancer Biology and Metastasis
Preclinical Drug Development for Pancreatic Cancer
Other Topics
Issue Navigation
Search within issue:
Search within issue
Abstracts: AACR Special Conference on Pancreatic Cancer: Advances in Science and Clinical Care; May 12-15, 2016; Orlando, FL
Clinical Investigation
Early Detection
Epidemiology and Risk Factors
Heterogeneity of Pancreatic Cancer
Immune Drug Development
Innovations and New Directions in Pancreatic Cancer Therapy
Molecular Drivers of Pancreatic Cancer Biology and Metastasis
Preclinical Drug Development for Pancreatic Cancer
Other Topics
All Issues
Advertisement
Email alerts
eTOC Alert
Close Modal
Latest
Most Read
Most Cited
Autocrine GMCSF Signaling Contributes to Growth of HER2
+
Breast Leptomeningeal Carcinomatosis
CHD1 promotes sensitivity to Aurora kinase inhibitors by suppressing interaction of AURKA with its coactivator TPX2
Metabolic reprogramming in hematological malignancies: advances and clinical perspectives
Squalene epoxidase metabolic dependency is a targetable vulnerability in castration-resistant prostate cancer
Close Modal
Close Modal
This Feature Is Available To Subscribers Only
Sign In
or
Create an Account
Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to
our privacy policy.
Accept
